Bioforce Nanosciences Holdings's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Bioforce Nanosciences Holdings's ROA in the second quarter of 2026?
Bioforce Nanosciences Holdings, Inc. recorded a cumulative net loss of $0 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -16.41%.

However, within the Healthcare sector BIOFORCE NANOSCIENCES HOLDINGS, INC. achieved the highest return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4732, from total ROA ranking in the first quarter of 2026 at 5457.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	265241.67 %	-54.35 %	-11.11 %	-50 %	28.57 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	0	0	-1	-1	-1
Return On Assets (TTM)	-16.41 %	-20900 %	-31705.52 %	-31621.95 %	-30293.02 %
BFNH's Total Ranking	# 4732	# 5457	# 4867	# 4938	# 5010
Total Assets (TTM) in million	2	0	0	0	0
Seq. Total Assets Change	37805.95 %	687.5 %	0 %	-11.11 %	-93.48 %
Seq. Net Income Change	-	-	-	-	-

BFNH's 5 Years Annual ROA >> Back to BFNH Management Effectiveness >> Compare BFNH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	# 0

Return On Assets Statistics
High	Average	Low
-16.41 %	-67108.5 %	-364339.77 %
(Jun 30 2026)		(Dec 31 2020)

Financial Statements
Bioforce Nanosciences Holdings's Assets	$ 2 million	BFNH's Balance sheet
Bioforce Nanosciences Holdings's Income	$ 0 million	Quarterly BFNH's Income Statement
BFNH's Income by Division		See BFNH's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-11.11 %	50 %	-14.29 %	-93.69 %	-72.16 %
Total Assets in million	0	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-1	0	0	0	-1
Annual Return On Assets	-161500 %	-54488.89 %	-78666.67 %	-69357.14 %	-4522.52 %

BFNH's 5 Years Annual ROA >> Back to BFNH Management Effectiveness >> Compare BFNH ROA to its Competitors

More Return On Assets Ratios
BFNH's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BFNH's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BFNH's Competitors
Subscribers only: Roa for Bioforce Nanosciences Holdings's Suppliers
Subscribers only: Return On Assets for BFNH's Customers

You may also want to know
BFNH's Roi	BFNH's Inventory Turnover Ratio	BFNH's Growth Rates	BFNH's Dividend Comparisons
	BFNH's Profitability Ratios	BFNH's Asset Turnover Ratio	BFNH's Dividend Growth
BFNH's Roe	BFNH's Valuation Ratios	BFNH's Financial Strength Ratios	BFNH's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-08-14T08:48:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.